Antiviral potentials of Lactobacillus plantarum, Lactobacillus amylovorus, and Enterococcus hirae against selected Enterovirus
Enteroviruses have been associated with a host of clinical presentations including acute flaccid paralysis (AFP). The site of primary replication for most enteroviruses is the gastrointestinal tract (GIT) and lactic acid bacteria (LAB) may confer protection in the GIT against them. This study therefore investigates the antiviral potential of some selected lactic acid bacteria against enterovirus isolates recovered from AFP cases. The antiviral activities of Lactobacillus plantarum, Lactobacillus amylovorus, and Enterococcus hirae in broth culture, their cell-free supernatant (CFS), and bacterial cell pellets were assayed against Echovirus 7 (E7), E13, and E19 in a pre- and post-treatment approach using cytopathic effect (CPE) and cell viability (MTT) assay. The tested Lactobacillus plantarum, Lactobacillus amylovorus, and Enterococcus hirae strains have good antiviral properties against E7 and E19 but not against E13. Lactobacillus amylovorus AA099 shows the highest activity against E19. The pre-treatment approach displays better antiviral activities compared to post-treatment approach. The LAB in broth suspension have better antiviral activities than their corresponding CFS and bacterial pellet. Lactic acid bacteria used in this study have the potential as antiviral agents.
Compliance with ethical standards
Conflict of interests
The authors declare that they have no conflict of interest.
- Alebiosu KM, Adetoye A, Ayeni FA (2017) Antimicrobial activities of lactic acid bacteria against Pseudomonas aeruginosa, Providencia vermicola, Alcaligenes faecalis and methicillin resistant S. aureus. West Afric J Pharm 28:132–142Google Scholar
- Bikila W (2015) Lactic acid bacteria: benefits, selection criteria and probiotic potential in fermented food. J Prob Health 3:129Google Scholar
- Conti C, Malaciino C, Mastromarino P (2009) Inhibition of herpes simplex virus type 2 by vaginal Lactobacilli. J Physiol Pharmacol 60:19–26Google Scholar
- Khani S, Motamedifar M, Golmoghaddam H, Hosseini HM, Hashemizadeh Z (2012) In vitro study of the effect of a probiotic bacterium Lactobacillus rhamnosus against herpes simplex virus type 1. Braz J Infect Dis 16:129–135Google Scholar
- Sayyed MHG, Mahboobeh MN Mahdi G, Zohreh K (2013) Probiotic therapy, what is the most effective method for host protection against enteric pathogen. Int J Entric Pathog 1:36–42Google Scholar
- Sobol CV, Bichurina MA (2009) Antiviral activity of Newfood probiotic product invitro. Int J Probiotics Prebiotics 4:229–232Google Scholar
- Tapparel C, Siegrist F, Petty TJ, Kaiser L (2013) Picornavirus and enterovirus diversity with associated human disease. Infect Genet Evol 12:505–521Google Scholar
- Vincenti JE (2010) The influence of cell-free Lactobacillus rhamnosus GG supernatant on the phagocytic activity of macrophages. Biohorizons 3:105–112Google Scholar
- World Health Organisation. Polio laboratory manual. 2004, 4th Edition, GenevaGoogle Scholar